Overjet
Total Raised
$130.55MInvestors Count
13Deal Terms
3Funding, Valuation & Revenue
8 Fundings
Overjet has raised $130.55M over 8 rounds.
Overjet's latest funding round was a Series C for $53.2M on March 5, 2024.
Overjet's valuation in December 2021 was $425M.
Overjet's latest post-money valuation is from March 2024.
Sign up for a free demo to see Overjet's valuations in March 2024, August 2021 and more.
Date | Round | Amount | Investors | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Revenue | Sources |
|---|---|---|---|---|---|---|
3/5/2024 | Series C | $53.2M | 6 | |||
3/5/2024 | Corporate Minority | |||||
12/20/2021 | Series B | ▲$425M | ||||
8/26/2021 | Series A | |||||
4/21/2020 | Seed VC - II |
Date | 3/5/2024 | 3/5/2024 | 12/20/2021 | 8/26/2021 | 4/21/2020 |
|---|---|---|---|---|---|
Round | Series C | Corporate Minority | Series B | Series A | Seed VC - II |
Amount | $53.2M | ||||
Investors | |||||
Valuation | ▲$425M | ||||
Revenue | |||||
Sources | 6 |
Overjet Deal Terms
3 Deal Terms
Overjet's deal structure is available for 3 funding rounds, including their Series C from March 05, 2024.
Round | Series C | Series B | Series A |
|---|---|---|---|
Funding Date | |||
Pre-Money Valuation | |||
Post-Money Valuation | |||
Amount Raised | |||
Shares Authorized | |||
Issuance Price | |||
Dividend Rate | |||
Liquidation Preferences | |||
Liquidation Price | |||
Participation | |||
Conversion Price | |||
Anti Dilution | |||
General Voting | |||
Board Voting | |||
Par Value |
Round | Funding Date | Pre-Money Valuation | Post-Money Valuation | Amount Raised | Shares Authorized | Issuance Price | Dividend Rate | Liquidation Preferences | Liquidation Price | Participation | Conversion Price | Anti Dilution | General Voting | Board Voting | Par Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Series C | |||||||||||||||
Series B | |||||||||||||||
Series A |
Overjet Investors
13 Investors
Overjet has 13 investors. E14 Fund invested in Overjet's Series C funding round.
First funding | Last Funding | Investor | Rounds | Board Seats | Type | Location |
|---|---|---|---|---|---|---|
4/21/2020 | 3/5/2024 | 4 Seed VC - II, Series A (2021), Series B (2021), Series C (2024) | Venture Capital | Massachusetts | ||
4/21/2020 | 3/5/2024 | 4 Seed VC - II, Series A (2021), Series B (2021), Series C (2024) | Venture Capital | California | ||
8/26/2021 | 3/5/2024 | 3 Series A, Series B (2021), Series C (2024) | Venture Capital | California | ||
Venture Capital | California | |||||
Private Equity | New York |
First funding | 4/21/2020 | 4/21/2020 | 8/26/2021 | ||
|---|---|---|---|---|---|
Last Funding | 3/5/2024 | 3/5/2024 | 3/5/2024 | ||
Investor | |||||
Rounds | 4 Seed VC - II, Series A (2021), Series B (2021), Series C (2024) | 4 Seed VC - II, Series A (2021), Series B (2021), Series C (2024) | 3 Series A, Series B (2021), Series C (2024) | ||
Board Seats | |||||
Type | Venture Capital | Venture Capital | Venture Capital | Venture Capital | Private Equity |
Location | Massachusetts | California | California | California | New York |
Compare Overjet to Competitors
VideaHealth develops artificial intelligence solutions for the dental industry. The company provides a dental artificial intelligence (AI) platform that aims to improve diagnostic accuracy and optimize practice workflows by combining clinical and workflow AI. VideaHealth targets dental service organizations (DSOs) and individual dental clinicians. VideaHealth was formerly known as DentistAI. It was founded in 2018 and is based in Boston, Massachusetts.
Pearl specializes in dental artificial intelligence (AI) solutions within the healthcare technology sector. Its main offerings include an AI-enabled radiologic platform for dental diagnostics and artificial intelligence services for dental practices. Its technology is utilized by the dental industry to improve the efficiency, accuracy, and consistency of dental care. It was founded in 2019 and is based in West Hollywood, California.
Denti.AI develops dental technology in the healthcare sector. The company offers products such as a dental scribe for recording clinician-patient conversations, voice-enabled perio charting for periodontal assessments, and automated X-ray diagnostics. Denti.AI primarily serves the dental healthcare industry, integrating its solutions with existing practice management systems to improve clinical workflows. It was founded in 2017 and is based in Toronto, Ontario.
Retrace is a company that provides payment solutions for the oral health care sector. It offers automation tools that assist with billing and office processes for dental practices. Retrace serves oral health care providers, payers, and patients by addressing claims processing. It was founded in 2016 and is based in San Francisco, California.
KELLS operates as an artificial intelligence-powered personal dental companion that operates in the healthcare technology sector. The company offers virtual and onsite dental evaluations, real-time advice, and treatment verification services to improve oral health care. KELLS primarily serves the healthcare industry by partnering with payors and providers to manage oral health risks and reduce costs. It was founded in 2018 and is based in Long Island City, New York.
Boneprox provides digital dental care and healthcare solutions, focusing on imaging and diagnostics. The company offers services including communication platforms for telediagnostics, AI for dental imaging analysis, and education programs for dental professionals. Boneprox serves the dental and healthcare sectors with its solutions. It was founded in 2013 and is based in Gothenburg, Sweden.
Loading...